/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.04%
Natural Gas
-1.29%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.53%
VIX
N/A
Economic Calendar
EUR/USD
-0.04%
Natural Gas
-1.29%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.53%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Gary Gensler to exit SEC on January 20: XRP, ADA, BNB prices react as Crypto Marketcap hit $3.23 Trillion
about 9 hours ago
EIA Natural Gas Report Reveals A Surprise Storage Draw Of -3 Bcf
about 15 hours ago
Weekly Unemployment Claims Decline as Manufacturing Activity Softens
about 16 hours ago
EIA: U.S. Crude Stocks Rise as Imports Surge, Refinery Activity Slows
1 day ago
UK Inflation Rate Jumps to 2.3% Hitting the Brakes on a BoE Rate Cut
2 days ago
October Housing Permits, Starts Miss Estimates Amid High Rates, Bearish Trends
2 days ago
Dax Index News: PMI and GDP Data Loom as DAX Eyes 19,350 Resistance
about 1 hour ago
Hang Seng Index Falls on Baidu Slumps; ASX 200 and Nikkei Advance
about 2 hours ago
XRP News Today: Gary Gensler Resigns, SEC Appeal in Limbo as BTC Hits $98k
about 4 hours ago
Gold, Bond Yield, US Dollar Technical Analysis: Bullish Trends Amid Geopolitical Tensions
about 5 hours ago
Japanese Yen and Australian Dollar News: Japan Inflation Fuels BoJ Rate Hike Bets
about 6 hours ago
Crude Oil Price Forecast: Crude Oil Continued to Creep Higher Within Consolidation
about 9 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
NBIX
news
Neurocrine Biosciences, Inc.
Follow
NBIX
(
Nasdaq - US
)
Closed
125.03
+1.74 (+1.41%)
in
:
usd
•
As of: Nov 21, 2024 15:59
UTC -5
Open
123.27
High
126.10
Low
122.50
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Seeking Alpha
Oct 30, 2024
Neurocrine Biosciences, Inc. (NBIX) Q3 2024 Earnings Call Transcript
NBIX
+1.41%
Zacks Investment Research
Oct 30, 2024
Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
NBIX
+1.41%
Zacks Investment Research
Oct 30, 2024
Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates
NBIX
+1.41%
Zacks Investment Research
Oct 23, 2024
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
NBIX
+1.41%
Seeking Alpha
Oct 10, 2024
Neurocrine: A Buy Amid CNS Pipeline Growth And Ingrezza's Strength (Rating Upgrade)
NBIX
+1.41%
The Motley Fool
Aug 30, 2024
Why Neurocrine Biosciences Stock Was Tumbling This Week
NBIX
+1.41%
Benzinga
Aug 29, 2024
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
NBIX
+1.41%
Zacks Investment Research
Aug 29, 2024
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
NBIX
+1.41%
Seeking Alpha
Aug 28, 2024
Neurocrine: Buying Opportunity After Stock Price Drop On Schizophrenia Data
NBIX
+1.41%
Seeking Alpha
Aug 28, 2024
Neurocrine Biosciences: Disappointing Data From A Key Readout Hits The Stock Hard
NBIX
+1.41%
Benzinga
Aug 28, 2024
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
BMY
+0.60%
Investors Business Daily
Aug 28, 2024
Neurocrine Bio Dives As Schizophrenia Trial Results Lag Peers
NBIX
+1.41%
Zacks Investment Research
Aug 6, 2024
Is Neurocrine (NBIX) a Solid Growth Stock? 3 Reasons to Think "Yes"
NBIX
+1.41%
Seeking Alpha
Aug 2, 2024
Neurocrine Biosciences Delivering Strong Core Results, And Significant Pipeline Value Could Be On The Way
NBIX
+1.41%
Seeking Alpha
Aug 1, 2024
Neurocrine Biosciences, Inc. (NBIX) Q2 2024 Earnings Call Transcript
NBIX
+1.41%
The Motley Fool
Aug 1, 2024
Neurocrine Biosciences' Revenue and Adjusted Income Surge
NBIX
+1.41%
Zacks Investment Research
Aug 1, 2024
Compared to Estimates, Neurocrine (NBIX) Q2 Earnings: A Look at Key Metrics
NBIX
+1.41%
Zacks Investment Research
Aug 1, 2024
Neurocrine Biosciences (NBIX) Lags Q2 Earnings Estimates
NBIX
+1.41%
Zacks Investment Research
Jul 31, 2024
Insights Into Neurocrine (NBIX) Q2: Wall Street Projections for Key Metrics
NBIX
+1.41%
Zacks Investment Research
Jul 25, 2024
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
NBIX
+1.41%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker